David Erlinge
21 – 30 of 463
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Ticagrelor Treatment is Associated With Increased Coronary Flow Reserve in Survivors of Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
PCI or CABG for left main coronary artery disease : The SWEDEHEART registry
(
- Contribution to journal › Article
-
Mark
Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction
(
- Contribution to journal › Article
-
Mark
Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients : PROSPECT II
(
- Contribution to journal › Article
-
Mark
Clinical Outcome of Revascularization Deferral With Instantaneous Wave-Free Ratio and Fractional Flow Reserve : A 5-Year Follow-Up Substudy From the iFR-SWEDEHEART Trial
(
- Contribution to journal › Article
-
Mark
Prognostic Value of Early Sustained Ventricular Arrhythmias in ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention : A Substudy of VALIDATE-SWEDEHEART Trial
(
- Contribution to journal › Article
-
Mark
Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial) : Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
(
- Contribution to journal › Article
-
Mark
Rationale and design of the DAPA-MI trial : Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction
(
- Contribution to journal › Article
-
Mark
Prognostic utility and characterization of left ventricular hypertrophy using global thickness
(
- Contribution to journal › Article